Advanced glycation end products promote the progression of chronic kidney diseases by targeting calpain 6-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advanced glycation end products promote the progression of chronic kidney diseases by targeting calpain 6

Published:2023-05-27 Issue:7 Volume:55 Page:903-912
ISSN:0939-4451
Container-title:Amino Acids
language:en
Short-container-title:Amino Acids

Author:

Zhang Yufan,Han Haiqiong,Qian Yu,Wang Qiong,Jiang Minmin

Funder

Topic of Shanghai Health Commission

The third batch of key disciplines of Traditional Chinese medicine in Jiading District, Shanghai

Jiangqiao town community Health service Center famous old Chinese medicine (school) studio

Shanghai Jiading District Health system "Jiading Medical Star" young talent training program scientific research project

Publisher

Springer Science and Business Media LLC

Subject

Organic Chemistry,Clinical Biochemistry,Biochemistry

Link

https://link.springer.com/content/pdf/10.1007/s00726-023-03282-5.pdf

Reference44 articles.

1. Bruck K, Stel VS, Gambaro G, Hallan S, Volzke H, Arnlov J et al (2016) CKD prevalence varies across the European general population. J Am Soc Nephrol 27:2135–2147

2. Chen L, Xiao D, Tang F, Gao H, Li X (2020) CAPN6 in disease: an emerging therapeutic target (Review). Int J Mol Med 46(5):1644–1652

3. D’Agati V, Schmidt AM (2010) RAGE and the pathogenesis of chronic kidney disease. Nat Rev Nephrol 6:352–360

4. Ding H, Jiang L, Xu J, Bai F, Zhou Y, Yuan Q et al (2017) Inhibiting aerobic glycolysis suppresses renal interstitial fibroblast activation and renal fibrosis. Am J Physiol Renal Physiol 313:F561–F575

5. Duan J, Wang C, Liu D, Qiao Y, Pan S, Jiang D et al (2019) Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in Chinese rural residents: a cross-sectional survey. Sci Rep 9:10408

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calcium signaling crosstalk between the endoplasmic reticulum and mitochondria, a new drug development strategies of kidney diseases;Biochemical Pharmacology;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3